Off-Label Use of Antipsychotics Effective for Some Indications
The Carlat Psychiatry Report, Volume 9, Number 12, December 2011
https://www.thecarlatreport.com/newsletter-issue/tcprv9n12/
Issue Links: Learning Objectives | Editorial Information
Topics: Antipsychotics | Dementia | OCD | PTSD | Substance Abuse
Glen Spielmans, PhD
Over the past decade or so, atypical antipsychotic use has exploded, for both FDA approved indications and off-label treatments.
You can't view details of this content, please login or buy subscription here
Glen Spielmans, PhD
Associate professor of psychology, Metropolitan State University, St. Paul, MN
Glen Spielmans, PhD, has disclosed that he has no relevant financial or other interests in any commercial companies ertaining to this educational activity.